2021 Q4 Form 10-Q Financial Statement
#000155837021015862 Filed on November 15, 2021
Income Statement
Concept | 2021 Q4 | 2021 Q3 | 2020 Q3 |
---|---|---|---|
Revenue | $8.550M | $12.05M | $10.79M |
YoY Change | -56.15% | 11.71% | -24.27% |
Cost Of Revenue | $3.150M | $3.703M | $2.868M |
YoY Change | 14.55% | 29.11% | -10.51% |
Gross Profit | $5.400M | $8.351M | $7.922M |
YoY Change | -67.74% | 5.42% | -28.26% |
Gross Profit Margin | 63.16% | 69.28% | 73.42% |
Selling, General & Admin | $3.470M | $2.954M | $2.816M |
YoY Change | 17.63% | 4.9% | 8.85% |
% of Gross Profit | 64.26% | 35.37% | 35.55% |
Research & Development | $7.640M | $7.282M | $7.688M |
YoY Change | -30.23% | -5.28% | -23.12% |
% of Gross Profit | 141.48% | 87.2% | 97.05% |
Depreciation & Amortization | $260.0K | $290.0K | $300.0K |
YoY Change | -10.34% | -3.33% | -30.23% |
% of Gross Profit | 4.81% | 3.47% | 3.79% |
Operating Expenses | $11.11M | $10.24M | $10.50M |
YoY Change | -20.13% | -2.55% | -16.55% |
Operating Profit | -$5.710M | -$1.885M | -$2.582M |
YoY Change | -301.77% | -26.99% | 67.23% |
Interest Expense | -$910.0K | -$2.310M | -$1.860M |
YoY Change | -62.7% | 24.19% | -7.92% |
% of Operating Profit | |||
Other Income/Expense, Net | -$50.00K | -$2.314M | -$1.855M |
YoY Change | 24.74% | -7.99% | |
Pretax Income | -$6.670M | -$4.200M | -$4.440M |
YoY Change | -1767.5% | -5.41% | 24.72% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$6.670M | -$4.199M | -$4.437M |
YoY Change | -1767.5% | -5.36% | 24.63% |
Net Earnings / Revenue | -78.01% | -34.83% | -41.12% |
Basic Earnings Per Share | -$0.09 | -$0.14 | |
Diluted Earnings Per Share | -$0.15 | -$0.09 | -$0.14 |
COMMON SHARES | |||
Basic Shares Outstanding | 45.56M | 45.56M | 32.86M |
Diluted Shares Outstanding | 45.56M | 32.86M |
Balance Sheet
Concept | 2021 Q4 | 2021 Q3 | 2020 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $39.00M | $10.60M | $13.50M |
YoY Change | 113.11% | -21.48% | -36.92% |
Cash & Equivalents | $38.99M | $10.64M | $13.53M |
Short-Term Investments | |||
Other Short-Term Assets | $1.285M | $2.274M | $2.612M |
YoY Change | -38.69% | -12.94% | -6.71% |
Inventory | $17.95M | $14.73M | $13.28M |
Prepaid Expenses | $905.0K | ||
Receivables | $3.442M | $5.561M | $3.146M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $61.67M | $71.22M | $60.33M |
YoY Change | 10.67% | 18.05% | 49.34% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $4.962M | $5.065M | $4.639M |
YoY Change | 2.41% | 9.18% | -58.95% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $2.100M | $1.900M | $1.600M |
YoY Change | 16.67% | 18.75% | -20.0% |
Total Long-Term Assets | $12.00M | $12.26M | $11.98M |
YoY Change | -1.74% | 2.34% | -9.94% |
TOTAL ASSETS | |||
Total Short-Term Assets | $61.67M | $71.22M | $60.33M |
Total Long-Term Assets | $12.00M | $12.26M | $11.98M |
Total Assets | $73.67M | $83.48M | $72.31M |
YoY Change | 8.44% | 15.45% | 34.66% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $16.43M | $8.400M | $8.400M |
YoY Change | 18.0% | 0.0% | 7.69% |
Accrued Expenses | $11.98M | $1.200M | $1.200M |
YoY Change | 24.98% | 0.0% | 0.0% |
Deferred Revenue | $8.550M | $15.16M | $16.72M |
YoY Change | 58.51% | -9.33% | |
Short-Term Debt | $0.00 | $0.00 | $4.300M |
YoY Change | -100.0% | -100.0% | |
Long-Term Debt Due | $3.200M | ||
YoY Change | |||
Total Short-Term Liabilities | $33.18M | $42.76M | $43.90M |
YoY Change | -61.63% | -2.58% | 31.82% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $27.90M | $27.80M | $53.60M |
YoY Change | 27800.0% | -48.13% | -3.42% |
Other Long-Term Liabilities | $18.60M | $12.70M | $46.00K |
YoY Change | 36370.59% | 27508.7% | -99.87% |
Total Long-Term Liabilities | $46.53M | $40.51M | $61.73M |
YoY Change | 447.55% | -34.38% | -32.31% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $33.18M | $42.76M | $43.90M |
Total Long-Term Liabilities | $46.53M | $40.51M | $61.73M |
Total Liabilities | $79.70M | $83.27M | $105.6M |
YoY Change | -16.08% | -21.17% | -15.23% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$374.9M | ||
YoY Change | 7.94% | ||
Common Stock | $368.9M | ||
YoY Change | 15.17% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$6.036M | $213.0K | -$33.32M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $73.67M | $83.48M | $72.31M |
YoY Change | 8.44% | 15.45% | 34.66% |
Cashflow Statement
Concept | 2021 Q4 | 2021 Q3 | 2020 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$6.670M | -$4.199M | -$4.437M |
YoY Change | -1767.5% | -5.36% | 24.63% |
Depreciation, Depletion And Amortization | $260.0K | $290.0K | $300.0K |
YoY Change | -10.34% | -3.33% | -30.23% |
Cash From Operating Activities | -$5.090M | -$1.880M | -$3.610M |
YoY Change | -32.58% | -47.92% | 12.11% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $450.0K | $340.0K | $100.0K |
YoY Change | 60.71% | 240.0% | -74.36% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $37.88M | $4.980M | $7.910M |
YoY Change | 381.93% | -37.04% | -15920.0% |
Cash From Investing Activities | $37.44M | $4.620M | $7.810M |
YoY Change | 393.28% | -40.85% | -1875.0% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -4.040M | -25.99M | 4.480M |
YoY Change | -186.88% | -680.13% | |
NET CHANGE | |||
Cash From Operating Activities | -5.090M | -1.880M | -3.610M |
Cash From Investing Activities | 37.44M | 4.620M | 7.810M |
Cash From Financing Activities | -4.040M | -25.99M | 4.480M |
Net Change In Cash | 28.31M | -23.25M | 8.680M |
YoY Change | 503.62% | -367.86% | -337.16% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$5.090M | -$1.880M | -$3.610M |
Capital Expenditures | $450.0K | $340.0K | $100.0K |
Free Cash Flow | -$5.540M | -$2.220M | -$3.710M |
YoY Change | -29.25% | -40.16% | 2.77% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.48 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.25 | ||
CY2021Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | |
CY2020Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.14 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43761769 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
27758104 | ||
CY2021Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
45556647 | |
CY2020Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32863788 | |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001006281 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-33357 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
PROTALIX BIOTHERAPEUTICS, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
65-0643773 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2 University Plaza | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 100 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Hackensack | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NJ | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
07601 | ||
dei |
City Area Code
CityAreaCode
|
201 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
696-9345 | ||
dei |
Security12b Title
Security12bTitle
|
Common stock, $0.001 par value | ||
dei |
Trading Symbol
TradingSymbol
|
PLX | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NYSEAMER | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2021Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
45556647 | |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10642000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18265000 | |
CY2021Q3 | plx |
Short Term Bank Deposits
ShortTermBankDeposits
|
38017000 | |
CY2020Q4 | plx |
Short Term Bank Deposits
ShortTermBankDeposits
|
20280000 | |
CY2021Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5561000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2000000 | |
CY2021Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2274000 | |
CY2020Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2096000 | |
CY2021Q3 | us-gaap |
Inventory Net
InventoryNet
|
14730000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
13082000 | |
CY2021Q3 | us-gaap |
Assets Current
AssetsCurrent
|
71224000 | |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
55723000 | |
CY2021Q3 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
1948000 | |
CY2020Q4 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
1799000 | |
CY2021Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5065000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4845000 | |
CY2021Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
5245000 | |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
5567000 | |
CY2021Q3 | us-gaap |
Assets
Assets
|
83482000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
67934000 | |
CY2021Q3 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
8436000 | |
CY2020Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
7221000 | |
CY2021Q3 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
14694000 | |
CY2020Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
13926000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1235000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1420000 | |
CY2021Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
15160000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
5394000 | |
CY2021Q3 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
3239000 | |
CY2020Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
54427000 | |
CY2020Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
4086000 | |
CY2021Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
42764000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
86474000 | |
CY2021Q3 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
27816000 | |
CY2021Q3 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
5895000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
1716000 | |
CY2021Q3 | us-gaap |
Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
|
2353000 | |
CY2020Q4 | us-gaap |
Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
|
2263000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
4441000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
4467000 | |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
51000 | |
CY2021Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
40505000 | |
CY2020Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
8497000 | |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
83269000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
94971000 | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
213000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-27037000 | |
CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
83482000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
67934000 | |
us-gaap |
Revenues
Revenues
|
29801000 | ||
us-gaap |
Revenues
Revenues
|
43403000 | ||
CY2021Q3 | us-gaap |
Revenues
Revenues
|
12054000 | |
CY2020Q3 | us-gaap |
Revenues
Revenues
|
10790000 | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
13201000 | ||
us-gaap |
Cost Of Revenue
CostOfRevenue
|
8121000 | ||
CY2021Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
3703000 | |
CY2020Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2868000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
22093000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
27214000 | ||
CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7282000 | |
CY2020Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7688000 | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
9263000 | ||
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8197000 | ||
CY2021Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2954000 | |
CY2020Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2816000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14756000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-129000 | ||
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1885000 | |
CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2582000 | |
us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
6613000 | ||
us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
7150000 | ||
CY2021Q3 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
2410000 | |
CY2020Q3 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
1973000 | |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
403000 | ||
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
359000 | ||
CY2021Q3 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
96000 | |
CY2020Q3 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
118000 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-6210000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-6791000 | ||
CY2021Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2314000 | |
CY2020Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1855000 | |
us-gaap |
Other Income
OtherIncome
|
51000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-20915000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-6920000 | ||
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4199000 | |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4437000 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.48 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.25 | ||
CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
CY2020Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.14 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43761769 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
27758104 | ||
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
45556647 | |
CY2020Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
32863788 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-70322000 | |
plx |
Issuance Of Common Stock And Warrants Net Of Issuance Cost Value
IssuanceOfCommonStockAndWarrantsNetOfIssuanceCostValue
|
41343000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1607000 | ||
plx |
Share Based Compensation Restricted Stock Awards Net Of Forfeitures
ShareBasedCompensationRestrictedStockAwardsNetOfForfeitures
|
505000 | ||
plx |
Stock Issued During Period Value Warrants Exercises
StockIssuedDuringPeriodValueWarrantsExercises
|
472000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-6920000 | ||
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-33315000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-27037000 | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
37625000 | ||
plx |
Stock Issued During Period Value Sales Agreement
StockIssuedDuringPeriodValueSalesAgreement
|
8575000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1176000 | ||
plx |
Share Based Compensation Restricted Stock Awards Net Of Forfeitures
ShareBasedCompensationRestrictedStockAwardsNetOfForfeitures
|
781000 | ||
plx |
Reacquisition Of Equity Component Of Convertible Notes
ReacquisitionOfEquityComponentOfConvertibleNotes
|
12019000 | ||
plx |
Equity Component Of Convertible Notes Net Of Transaction Costs
EquityComponentOfConvertibleNotesNetOfTransactionCosts
|
-12027000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-20915000 | ||
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
213000 | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-34764000 | |
CY2020Q3 | plx |
Receivables From Sale Of Common Stock And Warrants
ReceivablesFromSaleOfCommonStockAndWarrants
|
-4000000 | |
CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
909000 | |
CY2020Q3 | plx |
Share Based Compensation Restricted Stock Awards Net Of Forfeitures
ShareBasedCompensationRestrictedStockAwardsNetOfForfeitures
|
505000 | |
CY2020Q3 | plx |
Stock Issued During Period Value Warrants Exercises
StockIssuedDuringPeriodValueWarrantsExercises
|
472000 | |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4437000 | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-33315000 | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3841000 | |
CY2021Q3 | plx |
Reacquisition Of Equity Component Of Convertible Notes
ReacquisitionOfEquityComponentOfConvertibleNotes
|
12019000 | |
CY2021Q3 | plx |
Equity Component Of Convertible Notes Net Of Transaction Costs
EquityComponentOfConvertibleNotesNetOfTransactionCosts
|
12027000 | |
CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
344000 | |
CY2021Q3 | plx |
Share Based Compensation Restricted Stock Awards Net Of Forfeitures
ShareBasedCompensationRestrictedStockAwardsNetOfForfeitures
|
219000 | |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4199000 | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
213000 | |
CY2020Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-20915000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-6920000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1957000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2112000 | ||
us-gaap |
Depreciation
Depreciation
|
859000 | ||
us-gaap |
Depreciation
Depreciation
|
1011000 | ||
us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-118000 | ||
us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
284000 | ||
us-gaap |
Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
|
100000 | ||
us-gaap |
Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
|
-488000 | ||
plx |
Gain Loss On Amounts Funded In Respect Of Employee Rights Upon Retirement
GainLossOnAmountsFundedInRespectOfEmployeeRightsUponRetirement
|
75000 | ||
plx |
Gain Loss On Amounts Funded In Respect Of Employee Rights Upon Retirement
GainLossOnAmountsFundedInRespectOfEmployeeRightsUponRetirement
|
11000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
51000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-831000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2569000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2548000 | ||
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
13945000 | ||
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-15062000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4075000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-783000 | ||
plx |
Change In Operating Lease Right Of Use Assets
ChangeInOperatingLeaseRightOfUseAssets
|
-168000 | ||
plx |
Change In Operating Lease Right Of Use Assets
ChangeInOperatingLeaseRightOfUseAssets
|
-53000 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1648000 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
5126000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1070000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3291000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-51000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-463000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5198000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-18556000 | ||
plx |
Increase Decrease In Bank Deposits
IncreaseDecreaseInBankDeposits
|
37835000 | ||
plx |
Increase Decrease In Bank Deposits
IncreaseDecreaseInBankDeposits
|
27500000 | ||
plx |
Proceeds From Sale Of Short Term Deposits
ProceedsFromSaleOfShortTermDeposits
|
20000000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1011000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
380000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
53000 | ||
plx |
Increase Decrease In Restricted Deposit
IncreaseDecreaseInRestrictedDeposit
|
-359000 | ||
plx |
Increase Decrease In Restricted Deposit
IncreaseDecreaseInRestrictedDeposit
|
4000 | ||
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
81000 | ||
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-340000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-18515000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-27544000 | ||
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
25990000 | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
4086000 | ||
plx |
Proceeds From Issuance Of Common Stock And Warrants Net Of Issuance Cost
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfIssuanceCost
|
37625000 | ||
plx |
Proceeds From Issuance Of Common Stock And Warrants Net Of Issuance Cost
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfIssuanceCost
|
41343000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
8575000 | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
472000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
16124000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
41815000 | ||
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-34000 | ||
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
26000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-7623000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4259000 | ||
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18265000 | |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17792000 | |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10642000 | |
CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
13533000 | |
plx |
Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
|
387000 | ||
plx |
Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
|
95000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
309000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
564000 | ||
plx |
Debt Conversion Transaction Costs In Connection With Exchange Of Convertible Debt
DebtConversionTransactionCostsInConnectionWithExchangeOfConvertibleDebt
|
774000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
3288000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
2172000 | ||
plx |
Interest Received Net
InterestReceivedNet
|
445000 | ||
plx |
Interest Received Net
InterestReceivedNet
|
68000 | ||
CY2021Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
8749999 | |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
40200000 | |
CY2021Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
4.60 | |
CY2020Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
26905842 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
21405733 | ||
CY2021Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27962842 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
26847081 | ||
CY2021Q3 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
3170000 | |
CY2020Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
3347000 | |
CY2021Q3 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
3507000 | |
CY2020Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2887000 | |
CY2021Q3 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
8053000 | |
CY2020Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
6848000 | |
CY2021Q3 | us-gaap |
Inventory Net
InventoryNet
|
14730000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
13082000 | |
CY2021Q3 | plx |
Maintain Of Minimum Cash Balance
MaintainOfMinimumCashBalance
|
7500000 | |
CY2021Q3 | plx |
Debt Instrument Minimum Unrestricted Cash To Be Maintained
DebtInstrumentMinimumUnrestrictedCashToBeMaintained
|
3270000 |